News & Updates

A recent Singapore meta-analysis of randomized controlled trials (RCT) has found no clear clinical benefit to using convalescent plasma (CP) for patients with the coronavirus disease 2019 (COVID-19), especially in those with severe disease.

A recent study has shown that depression predicts the risk of developing heart failure (HF) with preserved ejection fraction (HFpEF) in late life, and the greater the symptoms, the higher the risk.

A decline in daily physical activity (DPA) among patients with idiopathic pulmonary fibrosis (IPF) over a year is noteworthy and disproportionate to a decline in pulmonary physiology, suggests a recent study, noting that this change in DPA may be used as a prognostic tool to assess disease progression.

Depression during physician training remains high, but the average increase in depressive symptoms associated with internship has declined from 2007 to 2019, results of a study have shown.